About Oculis Holding AG 
Oculis Holding AG
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Strategic Entities
Domestic Funds
Held in 4 Schemes (2.79%)
Foreign Institutions
Held by 11 Foreign Institutions (1.51%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2025)
Net Profit:
-31 Million
Pharmaceuticals & Biotechnology
USD 1,489 Million ()
NA (Loss Making)
NA
0.00%
-1.11
-58.77%
9.07






